Market Research Logo

Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review

Merck & Co Inc (MRK) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Merck & Co Inc (Merck) is a biopharmaceutical company that focuses on the discovery, development, manufacture and commercialization of prescription medicines, biologic therapies, vaccines and animal health products. It offers prescription products for treating cardiovascular, cancer, immune disorders, infectious, respiratory and women's diseases, and diabetes. The company provides animal health products including vaccines, poultry products, livestock products and aquaculture products. Merck sells medicines to drug wholesalers, retailers, hospitals, government agencies and managed health care providers; and animal health products to veterinarians, distributors and animal producers. Outside the US, the company operates through subsidiaries. It operates in the Americas, Europe, the Middle East, Africa, Asia Pacific, and Latin America. Merck is known as MSD outside the US and Canada and is headquartered in Kenilworth, New Jersey, the US.

Merck & Co Inc Key Recent Developments

Mar 20,2018: Merck Names Jennifer Zachary As General Counsel
Feb 19,2018: Gilead wins reversal in $2.5 billion dispute with Merck
Jan 24,2018: Merck Names Inge Thulin To Board Of Directors
Jan 23,2018: Merck Announces Second-Quarter 2018 Dividend
Dec 05,2017: Bioethics International Releases the Good Pharma Scorecard in BMJ Open, Ranking the Top 20 Largest Pharmaceutical Companies on Clinical Trial Transparency

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
Merck & Co Inc - Key Facts
Merck & Co Inc - Key Employees
Merck & Co Inc - Key Employee Biographies
Merck & Co Inc - Major Products and Services
Merck & Co Inc - History
Merck & Co Inc - Company Statement
Merck & Co Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Merck & Co Inc - Business Description
Business Segment: Animal Health
Overview
Performance
Business Segment: Other Revenues
Performance
Business Segment: Pharmaceuticals
Overview
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe, Middle East and Africa (EMEA)
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: Other regions
Performance
Geographical Segment: United States
Performance
R&D Overview
Merck & Co Inc - Corporate Strategy
Merck & Co Inc - SWOT Analysis
SWOT Analysis - Overview
Merck & Co Inc - Strengths
Merck & Co Inc - Weaknesses
Merck & Co Inc - Opportunities
Merck & Co Inc - Threats
Merck & Co Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Merck & Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Merck & Co Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Merck & Co Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 19, 2018: Gilead wins reversal in $2.5 billion dispute with Merck
Jan 23, 2018: Merck Announces Second-Quarter 2018 Dividend
Dec 05, 2017: Bioethics International Releases the Good Pharma Scorecard in BMJ Open, Ranking the Top 20 Largest Pharmaceutical Companies on Clinical Trial Transparency
Nov 27, 2017: MSD announces plan to establish UK Discovery Centre in London
Nov 13, 2017: PeptiDream Announces 2 nd Milestone from Macrocyclic Peptide Drug Discovery Alliance with Merck & Co., Inc., Kenilworth, N.J., U.S.A
Oct 27, 2017: Merck Announces Third-Quarter 2017 Financial Results
Oct 19, 2017: Merck Foundation Launches Five-Year Initiative to Improve Diabetes Care for Vulnerable and Underserved U.S. Communities
Oct 13, 2017: The Dispute with the Boards of Appeal of the European Patent Office between Merck & Co., Inc. regarding HIV integrase inhibitor
Oct 09, 2017: Johnson & Johnson investing $350M in EU biologics operation, adding 200 jobs
Aug 21, 2017: Bionomics & MSD 5th Annual Neuroscience Symposium in October
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Merck & Co Inc, Key Facts
Merck & Co Inc, Key Employees
Merck & Co Inc, Key Employee Biographies
Merck & Co Inc, Major Products and Services
Merck & Co Inc, History
Merck & Co Inc, Subsidiaries
Merck & Co Inc, Joint Venture
Merck & Co Inc, Key Competitors
Merck & Co Inc, Ratios based on current share price
Merck & Co Inc, Annual Ratios
Merck & Co Inc, Annual Ratios (Cont...1)
Merck & Co Inc, Annual Ratios (Cont...2)
Merck & Co Inc, Interim Ratios
Merck & Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Merck & Co Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
Merck & Co Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Merck & Co Inc, Performance Chart (2013 - 2017)
Merck & Co Inc, Ratio Charts
Merck & Co Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Merck & Co Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report